Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04972552 · ClinicalTrials.gov registry record · NA
Watermelon/UBIQuinone Study
A NA study of Kidney Transplantation, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04972552: Active NA study of Kidney Transplantation, sponsored by University of California, San Francisco.
NCT04972552 is a NA study of Kidney Transplantation that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 70 participants, below the 266-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04972552, a NA study of Kidney Transplantation, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.
Primary Outcome
We will determine the number of patients who drop out of the study following randomized assignment
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Usual Diet
- DIETARY_SUPPLEMENT coenzyme Q10
- OTHER Watermelon diet
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT04972552 still lists
NCT04972552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 266-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Kidney Transplantation appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT04972552 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04972552 about?
NCT04972552 is a clinical study titled "Watermelon/UBIQuinone Study". The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.
What is the current status of trial NCT04972552?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-11-15. Estimated completion is 2026-06-30.
What conditions does trial NCT04972552 study?
This clinical trial studies the following conditions: Kidney Transplantation.
What interventions are being tested in trial NCT04972552?
The interventions under investigation include: Placebo (OTHER), Usual Diet (OTHER), coenzyme Q10 (DIETARY_SUPPLEMENT), Watermelon diet (OTHER).
Who is sponsoring clinical trial NCT04972552?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04972552 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04972552's enrollment target sits among peer trials
70 20th of 33 higher than 14 of 33 other Kidney Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
RECRUITING · NA
-
APOL1 Genetic Testing Program for Living Donors
ACTIVE NOT RECRUITING · NA
-
Vitamin D Replacement After Kidney Transplant
COMPLETED · NA
-
Intervention to Improve Adherence in Teen Kidney Transplant
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI